Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003
Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and efficacy of CNTO 136
(sirukumab) in participants with rheumatoid arthritis (RA) who are unresponsive to treatment
with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents.